Celebrating Our Successes of 2024
As 2024 draws to a close, we’re reflecting on an incredible year for our team. Since formally moving to QMUL at the end of 2023… Read More »Celebrating Our Successes of 2024
Clinical Trials
Targeted trials to reduce research waste
Dr. Adam Brentnall is a Statistician from Barts Clinical Trials Unit, Wolfson Institute of Population Health, Queen Mary University of London (QMUL). He also works… Read More »Targeted trials to reduce research waste
Treatment for locally advanced cervical cancer: INTERLACE
A phase III multicentre trial of weekly induction chemotherapy followed by standard chemoradiation versus standard chemoradioation alone, in patients with locally advanced cervical cancer Aim:… Read More »Treatment for locally advanced cervical cancer: INTERLACE
Measuring Quality of Life in Cancer Treatment: A Historical Focus
Carsten Timmermann is a historian of biomedicine and Director of the Centre for the History of Science, Technology and Medicine at the University of Manchester.… Read More »Measuring Quality of Life in Cancer Treatment: A Historical Focus
The BEST4 Oesophageal Cancer Trial: marking the beginning of patient recruitment
This post was written by Chris Deeley. Chris is the Trial Coordinator for the BEST4 Screening trial, managed by the Cancer Prevention Trials Unit (CPTU)… Read More »The BEST4 Oesophageal Cancer Trial: marking the beginning of patient recruitment
5 minutes with: Professor Melinda Irwin
Melinda L. Irwin is the Susan Dwight Bliss Professor of Epidemiology and Associate Dean of Research at the Yale School of Public Health, Deputy Director of the Yale… Read More »5 minutes with: Professor Melinda Irwin
5 minutes with: Professor Deborah Ashby
Professor Deborah Ashby is Director of the School of Public Health at Imperial College London where she holds the Chair in Medical Statistics and Clinical Trials,… Read More »5 minutes with: Professor Deborah Ashby